650 related articles for article (PubMed ID: 32985017)
21. A mini-review of the anti-SARS-CoV-2 potency of Amaryllidaceae alkaloids.
Le NT; Janssen K; Kirchmair J; Pieters L; Tuenter E
Phytomedicine; 2024 Jul; 129():155576. PubMed ID: 38579643
[TBL] [Abstract][Full Text] [Related]
22. Glycyrrhizin: An old weapon against a novel coronavirus.
Chrzanowski J; Chrzanowska A; Graboń W
Phytother Res; 2021 Feb; 35(2):629-636. PubMed ID: 32902005
[TBL] [Abstract][Full Text] [Related]
23. Natural Products from Medicinal Plants with Anti-Human Coronavirus Activities.
Hafez Ghoran S; El-Shazly M; Sekeroglu N; Kijjoa A
Molecules; 2021 Mar; 26(6):. PubMed ID: 33800977
[TBL] [Abstract][Full Text] [Related]
24. Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets.
He Z; Yuan J; Zhang Y; Li R; Mo M; Wang Y; Ti H
Pharm Biol; 2023 Dec; 61(1):1186-1210. PubMed ID: 37605622
[TBL] [Abstract][Full Text] [Related]
25. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
Choy KT; Wong AY; Kaewpreedee P; Sia SF; Chen D; Hui KPY; Chu DKW; Chan MCW; Cheung PP; Huang X; Peiris M; Yen HL
Antiviral Res; 2020 Jun; 178():104786. PubMed ID: 32251767
[TBL] [Abstract][Full Text] [Related]
26. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
Dzobo K; Chiririwa H; Dandara C; Dzobo W
OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
[TBL] [Abstract][Full Text] [Related]
27. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
28. In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea.
Bajrai LH; El-Kafrawy SA; Hassan AM; Tolah AM; Alnahas RS; Sohrab SS; Rehan M; Azhar EI
Sci Rep; 2022 Dec; 12(1):21723. PubMed ID: 36522420
[TBL] [Abstract][Full Text] [Related]
29. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
Su HX; Yao S; Zhao WF; Li MJ; Liu J; Shang WJ; Xie H; Ke CQ; Hu HC; Gao MN; Yu KQ; Liu H; Shen JS; Tang W; Zhang LK; Xiao GF; Ni L; Wang DW; Zuo JP; Jiang HL; Bai F; Wu Y; Ye Y; Xu YC
Acta Pharmacol Sin; 2020 Sep; 41(9):1167-1177. PubMed ID: 32737471
[TBL] [Abstract][Full Text] [Related]
30. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
[TBL] [Abstract][Full Text] [Related]
31. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
32. Impact of Traditional Plants and their Secondary Metabolites in the Discovery of COVID-19 Treatment.
Bibi S; Sarfraz A; Mustafa G; Ahmad Z; Zeb MA; Wang YB; Khan T; Khan MS; Kamal MA; Yu H
Curr Pharm Des; 2021; 27(9):1123-1143. PubMed ID: 33213320
[TBL] [Abstract][Full Text] [Related]
33. Promising natural products against SARS-CoV-2: Structure, function, and clinical trials.
Zhao Y; Deng S; Bai Y; Guo J; Kai G; Huang X; Jia X
Phytother Res; 2022 Oct; 36(10):3833-3858. PubMed ID: 35932157
[TBL] [Abstract][Full Text] [Related]
34. Possible therapeutic effects of
Khazdair MR; Ghafari S; Sadeghi M
Pharm Biol; 2021 Dec; 59(1):696-703. PubMed ID: 34110959
[TBL] [Abstract][Full Text] [Related]
35. Human coronaviruses and therapeutic drug discovery.
Song LG; Xie QX; Lao HL; Lv ZY
Infect Dis Poverty; 2021 Mar; 10(1):28. PubMed ID: 33726861
[TBL] [Abstract][Full Text] [Related]
36. Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.
Lee M; Park J; Cho IH
Am J Chin Med; 2022; 50(4):927-959. PubMed ID: 35729089
[TBL] [Abstract][Full Text] [Related]
37. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.
Wijayasinghe YS; Bhansali P; Viola RE; Kamal MA; Poddar NK
Curr Pharm Des; 2021; 27(33):3526-3550. PubMed ID: 33213322
[TBL] [Abstract][Full Text] [Related]
38. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents.
Nandi S; Roy H; Gummadi A; Saxena AK
Curr Drug Targets; 2021; 22(17):2006-2020. PubMed ID: 33687893
[TBL] [Abstract][Full Text] [Related]
39. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
Singh M; Trivedi D; Mohapatra R; Bagchi T; Durthi CP; Kuppam C
Curr Pharm Des; 2021 Oct; 27(31):3389-3398. PubMed ID: 34225610
[TBL] [Abstract][Full Text] [Related]
40. Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery.
Sternberg A; McKee DL; Naujokat C
Curr Top Med Chem; 2020; 20(16):1423-1433. PubMed ID: 32416679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
